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Brief Clinical ReportsEarly structural valve deterioration of 18-mm Sorin Soprano aortic
pericardial bioprosthesisLuis Fernando Lo´pez Almodo´var, MD, Pedro Lima, MD, Alfonso Can˜as, MD, Jose´ Buendı´a, MD, and
Emilio Monguio´, MD, Toledo, SpainFIGURE 1. Explanted prosthesis shows intrinsic and vegetating calcifica-
tions in all leaflets with calcified tear in noncoronary leaflet.Structural valve deterioration has been defined as any
changes intrinsic to the prosthetic valve leading to either
stenosis or regurgitation. Factors associated with structural
valve dysfunction include wear, calcification, leaflet tear,
and stent creep. We present the case of a patient with 18-
mm Sorin Soprano aortic pericardial bioprosthesis (Sorin Bi-
omedica Cardio SpA, Saluggia, Italy) with significant aortic
valve stenosis and regurgitation necessitating explantation 2
years after the initial procedure. Cases of immediate structural
dysfunction with this prosthesis have not yet been reported.
CLINICAL SUMMARY
A 72-year-old man was admitted to our institution with
severe aortic valve stenosis. He had a severely calcified
trileaflet aortic valve. An aortic valve replacement with an
18-mm Sorin Soprano pericardial valve was performed
with 2-0 pledgeted mattress sutures. Routine transthoracic
echocardiography performed on postoperative day 5 showed
an elevated peak transvalvular gradient (57 mm Hg), but the
patient had no symptoms and was discharged home. The
patient did well for 2 years, at which time symptomatic
deterioration with dyspnea was seen. Transthoracic echocar-
diography revealed aortic prosthesis dysfunction with severe
stenosis and moderate regurgitation.
A reoperation was performed, and examination of the
prosthesis before explantation showed the valve to be well
seated in the supra-annular position. The prosthesis was ste-
notic because of intrinsic and vegetating calcifications in all
leaflets, and a calcified tear in the noncoronary leaflet re-
sulted in a lack of leaflet coaptation, causing aortic regurgi-
tation (Figure 1). The valve was replaced with a 19-mm
mechanical valve. The patient recovered completely and
was discharged uneventfully.From the Cardiac Surgery Department, Virgen de la Salud Hospital, Toledo, Spain.
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Pericardial valve prosthesis has been associated with ex-
cellent long-term clinical results, and immediate structural
valve deterioration is rare.1 Structural valve deterioration in-
cludes changes intrinsic to the valve, including wear, calci-
fication, leaflet tear, and stent creep, but excludes infection
or thrombosis, as determined at explantation.2 In most pa-
tients, calcification is the cause of structural valve dysfunc-
tion requiring explantation.
The Sorin Soprano valve, a pericardial tissue valve de-
signed for a totally supra-annular seating, is in widespread
use in Europe.3 It has been marketed since May 2003. Valve
leaflets are manufactured in a unique two-sheet design with
glutaraldehyde-stabilized bovine pericardium posttreated
with a detoxification process. The exclusive detoxification
treatment with homocysteic acid neutralizes residues of
unbound aldehyde groups after the fixation process. The
product thus does not contain glutaraldehyde residues and
is therefore ready to implant without rinsing.
Sorin Biomedica Cardio was contacted, and the prosthesis
was sent to the manufacturer for analysis. Sorin has confirmed
that the cause of this valve structural deterioration was related
to large intrinsic and vegetating calcifications affecting all the
leaflets and causing stenosis (mean calcification score 3.33
out of 4). This prosthesis was initially stenotic because of in-
trinsic and vegetating calcifications in all leaflets and subse-
quently became insufficient because of tears. In this case,ery c April 2010
Brief Clinical Reportsa calcified tear in the noncoronary leaflet with perforation was
observed. It is difficult to determine whether the tear was pri-
mary or calcium related.4 Probably, the presence of these cal-
cium depositions encouraged tearing. We speculate that the
postoperative finding of elevated peak transvalvular gradient
was associated with a dynamic obstruction in the left ventric-
ular outlet, and this situation led to mechanical stress during
the systolic phase. The right coronary leaflet had intrinsic
and vegetating calcifications with stiffness but without tear-
ing. In addition, the commissural areas were severely calci-
fied. These areas are designed to absorb and distribute the
mechanical stress during the cardiac cycle. Thus when the
leaflets are opened, they are completely free of stresses. Al-
though a stent distortion is extremely rare and unusual, we
can not reject this possibility completely.From the Deutsches Herzzentrum Berlin, Department of Cardiothoracic and Vascular
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The Journal of Thoracic and CaThe Sorin Biomedica Cardio technical report concludes
that in presence of severe aortic stenosis and massive calci-
fication before the implant, calcifications may have been
triggered by the presence of such risk factors as hyperlipid-
emia and hypercholesterolemia.
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explants. Ann Thorac Surg. 2006;82:2337-2342.Complete destruction of a tissue-engineered porcine xenograft in
pulmonary valve position after the Ross procedureNicola E. Hiemann, MD,a Marjam Mani, MD,b Michael Huebler, MD,a Rudolf Meyer, MD, PhD,a
Roland Hetzer, MD, PhD,a Roland Thieme, MD,b and Christian Bethge, MD, PhD,b Berlin, GermanyThe Ross procedure is an attractive technique for aortic
valve replacement using a viable pulmonary autograft. Cur-
rent data from the German Ross Registry show favorable
clinical and hemodynamic results.1 Pilot work on the use
of a tissue-engineered decellularized porcine xenograft for
right ventricular outflow tract reconstruction has reported
excellent early and midterm results.2,3 We report a case
of recurrent right-sided heart failure after the Ross proce-
dure caused by complete destruction of the pulmonary
xenograft.CLINICAL SUMMARY
A 61-year-old male patient underwent the Ross procedure
for calcified aortic valve stenosis and received a tissue-engi-neered porcine xenograft (Matrix P, diameter 28 mm; Auto-
Tissue GmbH, Berlin, Germany) for reconstruction of the
right ventricular outflow tract. Four weeks after surgery, se-
vere dyspnea developed in the patient, and the chest x-ray in-
dicated abundant right-sided pleural effusion without
evidence of pulmonary infection in computed tomography,
bronchoscopy, or serology. Because of refractory pleural
transudation, the patient underwent right-sided partial pleur-
ectomy. Ten months later, he presented with severe dyspnea
and progressive weight loss (35 kg since Ross operation).
Outpatient echocardiography showed a pulmonary peak ve-
locity of 1.5 m/s without any signs of regurgitation, preserved
left ventricular ejection fraction, and minimal aortic autograft
regurgitation. Because objective physical fitness was good
(100W in ergometry), the patient was scheduled for ambula-
tory follow-up 2 weeks later. Echocardiography revealed en-
largement of the right ventricle and moderate hypertrophy.
Morphologic evaluation of the pulmonary xenograft was
scarcely feasible. Mean and peak pulmonary pressure gradi-
ents were 10 and 22 mm Hg, respectively; peak velocity was
1.9 m/s, and there was mild early diastolic regurgitation. Sys-
tolic pulmonary pressure was estimated at 55 mm Hg, indi-
cating moderate to severe pulmonary hypertension. Two
weeks later the patient was hospitalized again for severe
dyspnea and newly developed left-sided pleural effusion.
Transthoracic echocardiography demonstrated progressiverdiovascular Surgery c Volume 139, Number 4 e67
